Mild Hypoxic Ischaemic Encephalopathy of Newborn clinical trials at University of California Health
1 in progress, 0 open to eligible people
Sorry, not yet accepting patients
To determine effectiveness of therapy to improve neurodevelopmental outcomes in infants with mild HIE. To determine the adverse effects of TH in mild HIE on the neonate and his/her family. Determine heterogeneity of the treatment effect across key subgroups obtained in the first 6 hours after birth prior to the decision to initiate therapy.